$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 45/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 45/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,486 | 168,036 | 42,195 | |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,700 | 174,591 | 47,681 | |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 557.14 | 1,223 | 681,382 | 0 | 1.2 K to 0 (-100.00 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 556.00 | 1,000 | 556,000 | 1,223 | 2.2 K to 1.2 K (-44.98 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 554.39 | 2,000 | 1,108,780 | 2,223 | 4.2 K to 2.2 K (-47.36 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 552.50 | 50 | 27,625 | 4,223 | 4.3 K to 4.2 K (-1.17 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 551.45 | 850 | 468,733 | 4,273 | 5.1 K to 4.3 K (-16.59 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,674 | 1,496,076 | 5,123 | 7.8 K to 5.1 K (-34.30 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 300 | 167,847 | 7,797 | 8.1 K to 7.8 K (-3.71 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,486 | 168,036 | 8,097 | 2.6 K to 8.1 K (+210.11 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,778 | 1,554,263 | 2,611 | 5.4 K to 2.6 K (-51.55 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 311 | 174,001 | 5,389 | 5.7 K to 5.4 K (-5.46 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,700 | 174,591 | 5,700 | 0 to 5.7 K |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 30.63 | 75,000 | 2,297,250 | 46,736 | |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 21.25 | 25,000 | 531,250 | 20,295 | |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.41 | 900 | 507,069 | 22,029 | 22.9 K to 22 K (-3.93 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.31 | 5,607 | 3,152,872 | 22,929 | 28.5 K to 22.9 K (-19.65 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 561.36 | 500 | 280,680 | 28,536 | 29 K to 28.5 K (-1.72 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 560.31 | 3,900 | 2,185,209 | 29,036 | 32.9 K to 29 K (-11.84 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 559.26 | 1,500 | 838,890 | 32,936 | 34.4 K to 32.9 K (-4.36 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 558.37 | 9,694 | 5,412,839 | 34,436 | 44.1 K to 34.4 K (-21.97 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 564.19 | 2,100 | 1,184,799 | 44,130 | 46.2 K to 44.1 K (-4.54 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.43 | 8,345 | 4,701,823 | 46,230 | 54.6 K to 46.2 K (-15.29 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.37 | 9,555 | 5,373,445 | 54,575 | 64.1 K to 54.6 K (-14.90 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 13,312 | 7,556,291 | 64,130 | 77.4 K to 64.1 K (-17.19 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 935 | 530,734 | 77,442 | 78.4 K to 77.4 K (-1.19 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 21.25 | 25,000 | 531,250 | 78,377 | 53.4 K to 78.4 K (+46.84 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 39,605 | 22,480,986 | 53,377 | 93 K to 53.4 K (-42.59 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 4,047 | 2,297,199 | 92,982 | 97 K to 93 K (-4.17 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 30.63 | 75,000 | 2,297,250 | 97,029 | 22 K to 97 K (+340.46 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 1,000 | 0 | 16,405 | 17.4 K to 16.4 K (-5.75 %) |